Manage your subscription

Just say no

Published 30 November 2011

From
Ben Butler

Reading Susan Watts’s piece on the use of cognitive-enhancing drugs (19 November, p 32), I was both excited and shocked. I am studying management accountancy, and happy to consider things that would give me an edge over other students. Yet performance-enhancing drugs are, for me, a step too far.

The ethics of using drugs such as modafinil would appear to be in the same realm as cyclists using the hormone EPO to boost red blood cells, or the steroid nandrolone. I see it as highly unfair that what I hope to achieve through application, study and graft (with the odd …